Drugs / CTL MEP vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00111605 | ? → May 2008 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTL MEP vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00111605 ↗ |
| Modality | Vaccine | “CTL MEP/RC529-SE/GM-CSF (CTL MEP vaccine)” NCT00111605 ↗ |
| Route | Intramuscular | “A 1 mL intramuscular injection in the deltoid” NCT00111605 ↗ |